[See Order of the Commissioner of Public Health, dated April 6, 2020, (2019 MA EO H20-24) related to the COVID-19 State of Emergency, for potential impact on the terms of this section.]
Section 20. (a) Upon receiving an oral prescription for a controlled substance or instrument described in section twenty-seven from an authorized practitioner, the pharmacist shall immediately reduce the prescription to writing on a prescription form and shall record the name, address and registration number of the practitioner and the name of any expressly authorized representative, the date of the prescription, the name, dosage and strength per dosage unit of the controlled substance, the serial number assigned to the prescription by the dispensing pharmacy, the name of said pharmacy, the name and address of the patient unless it is a veterinary prescription, the directions for use and any cautionary statements required, and a statement indicating the number of times to be refilled.
(b) If the prescribing practitioner is not known to the pharmacist, he shall make a reasonable effort to determine that the oral authorization came from a registered practitioner.
(c) Whenever a practitioner prescribes a controlled substance by oral prescription, the practitioner shall cause an electronic prescription for the prescribed controlled substance to be delivered to the dispensing pharmacy within 2 days; provided, however, that if the practitioner has received an exception from using an electronic prescription from the commissioner pursuant to subsection (h) of section 23, the practitioner shall, within a period of not more than 7 days or such shorter period that is required by federal law, cause a written prescription for the prescribed controlled substance to be delivered to the dispensing pharmacy. The written prescription may be delivered to the pharmacy in person or by mail, but shall be postmarked within 7 days or such shorter period that is required by federal law. When an electronic or written prescription is issued pursuant to this subsection, the practitioner shall indicate on the electronic or written prescription that such prescription is being issued to document an oral prescription. Upon receipt, the dispensing pharmacy shall attach said prescription to the oral prescription which the pharmacy has reduced to writing. Persons charged with the enforcement of this chapter shall report violations of this subsection to the board of registration in medicine, the board of registration in dentistry, the board of registration in podiatry or the board of registration in veterinary medicine, whichever is applicable, and to the commissioner or board of registration in pharmacy, whichever is applicable. The requirements of this subsection shall not apply to controlled substances in Schedule VI of section 3.
Structure Massachusetts General Laws
Part I - Administration of the Government
Title XV - Regulation of Trade
Chapter 94c - Controlled Substances Act
Section 2 - Establishment of Schedules of Drugs or Other Controlled Substances
Section 2a - Temporary Placement of Substance in Schedule I
Section 3 - Findings Required for Placement in Schedules
Section 4 - Exceptions From Schedules
Section 5 - Dispensing Controlled Substances Excepted Under Sec. 4
Section 6 - Rules and Regulations
Section 7a - Registration as Participant in Prescription Monitoring Program
Section 8 - Research Projects and Studies
Section 10 - Separate Registration
Section 11 - Inspection of Establishments of Registrants or Applicants
Section 12 - Issuance of Registration to Manufacture or Distribute Controlled Substances
Section 16 - Distribution Between Registrants; Order Form
Section 17 - Necessity of Prescription for Dispensing Controlled Substances
Section 18 - Issuance of Prescription by Practitioner or Physician
Section 18b - Voluntary Non-Opiate Directive Form
Section 18c - Patient Education Required Before Issuance of Opioid Prescription
Section 19 - Prescription; Restrictions on Issuance
Section 19a - Emergency Contraception
Section 19b - Dispensing, Possessing and Administrating Opioid Antagonist
Section 19b1/2 - Exchange of Naloxone or Other Opioid Antagonist Between Registered Entities
Section 19d - Supply Limitations for Opiate Prescriptions; Exception for Palliative Care
Section 20 - Oral Prescriptions
Section 20a - Radiopharmaceutical Drugs
Section 21a - Prescriptions; Prospective Drug Review and Counseling by Pharmacist
Section 21b - Advertisement and Sale of Prescription Lock Boxes by Pharmacies
Section 22 - Contents of Prescription Written by Practitioner
Section 23 - Written or Electronic Prescriptions; Requirements and Restrictions
Section 27 - Sale of Hypodermic Syringes or Hypodermic Needles
Section 28 - Jurisdiction of Superior Court
Section 29 - Educational Programs for Prevention of Abuse of Controlled Substances
Section 30 - Administrative Inspection of Controlled Premises
Section 32k - Inducing or Abetting Minor to Distribute or Sell Controlled Substances
Section 32m - Possession of 2 Ounces or Less of Marihuana; Drug Awareness Program
Section 37 - Theft of Controlled Substances From Persons Authorized to Dispense or Possess
Section 38 - Violation of Secs. 24(a), 25, 26 or 27
Section 39 - Violation of Secs. 21 or 22
Section 41 - Arrest Without Warrant
Section 42 - Cooperation With Federal and Other State Agencies
Section 43 - Conformity With Federal Acts
Section 45 - Photographing and Fingerprinting of Persons Charged With Felony